Burn Center Care of Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

被引:15
作者
Cartotto, Robert [1 ]
机构
[1] Univ Toronto, Sunnybrook Hlth Sci Ctr, Ross Tilley Burn Ctr, Dept Surg, Room D712,1075 Bayview Ave, Toronto, ON M4N 3M5, Canada
关键词
Toxic epidermal necrolysis; Stevens-Johnson syndrome; Burn center; Exfoliative conditions; INTRAVENOUS IMMUNOGLOBULIN; HLA-B-ASTERISK-1502; ALLELE; ERYTHEMA MULTIFORME; CLINICAL-PATTERNS; FAS LIGAND; REQUIREMENTS; CYCLOSPORINE; EXPERIENCE; MANAGEMENT; MORTALITY;
D O I
10.1016/j.cps.2017.02.016
中图分类号
R61 [外科手术学];
学科分类号
摘要
Stevens-Johnson syndrome and toxic epidermal necrolysis are rare, life-threatening, cutaneous drug reactions. Medications are the most common cause, although an infection may be responsible. A link between genetics and certain medications has been established. Clinical diagnosis should be confirmed with biopsy. When the area of epidermal detachment approaches 30%, burn center care is advisable. An ophthalmologist should be consulted to optimize ocular care. Pharmacologic interruption has been sought but there is little consensus on the most appropriate agent and no high-quality studies have been conducted to demonstrate if any of these agents lead to improved survival.
引用
收藏
页码:583 / +
页数:14
相关论文
共 63 条
  • [1] Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand
    Abe, R
    Shimizu, T
    Shibaki, A
    Nakamura, H
    Watanabe, H
    Shimizu, H
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2003, 162 (05) : 1515 - 1520
  • [2] Arévalo JM, 2000, J TRAUMA, V48, P473
  • [3] Arnold R, 1999, J IMMUNOL, V162, P7140
  • [4] Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis - Results of an international prospective study
    Auquier-Dunant, A
    Mockenhaupt, M
    Naldi, L
    Correia, O
    Schroder, W
    Roujeau, JC
    [J]. ARCHIVES OF DERMATOLOGY, 2002, 138 (08) : 1019 - 1024
  • [5] SCORTEN: A severity-of-illness score for toxic epidermal necrolysis
    Bastuji-Garin, S
    Fouchard, N
    Bertocchi, M
    Roujeau, JC
    Revuz, J
    Wolkenstein, P
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (02) : 149 - 153
  • [6] CLINICAL CLASSIFICATION OF CASES OF TOXIC EPIDERMAL NECROLYSIS, STEVENS-JOHNSON SYNDROME, AND ERYTHEMA MULTIFORME
    BASTUJIGARIN, S
    RZANY, B
    STERN, RS
    SHEAR, NH
    NALDI, L
    ROUJEAU, JC
    [J]. ARCHIVES OF DERMATOLOGY, 1993, 129 (01) : 92 - 96
  • [7] Toxic epidermal necrolysis:: Use of Biobrane® for skin coverage reduces pain, improves mobilisation and decreases infection in elderly patients
    Boorboor, P.
    Vogt, P. M.
    Bechara, F. G.
    Alkandari, Q.
    Aust, M.
    Gohritz, A.
    Spies, M.
    [J]. BURNS, 2008, 34 (04) : 487 - 492
  • [8] TOXIC EPIDERMAL NECROLYSIS - A REVIEW AND REPORT OF THE SUCCESSFUL USE OF BIOBRANE FOR EARLY WOUND COVERAGE
    BRADLEY, T
    BROWN, RE
    KUCAN, JO
    SMOOT, EC
    HUSSMANN, J
    [J]. ANNALS OF PLASTIC SURGERY, 1995, 35 (02) : 124 - 132
  • [9] Toxic epidermal necrolysis: Does immunoglobulin make a difference?
    Brown, KM
    Silver, GM
    Halerz, M
    Walaszek, P
    Sandroni, A
    Gamelli, RL
    [J]. JOURNAL OF BURN CARE & REHABILITATION, 2004, 25 (01): : 81 - 88
  • [10] SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center
    Cartotto, Rob
    Mayich, Mike
    Nickerson, Duncan
    Gomez, Manuel
    [J]. JOURNAL OF BURN CARE & RESEARCH, 2008, 29 (01) : 141 - 146